IL4 and hereditary clear cell renal cell carcinoma: In a phase II trial of advanced renal cell carcinoma where 49 patients were treated with subcutaneous injection of IL-4 at 5 mcg/kg per day for 28 days, no complete or partial responses were observed [192].